Navigation Links
NeurogesX to Present at Upcoming Fall Conferences
Date:9/2/2009

ward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to the timing and outcome of regulatory decisions and label approval being sought or that may be obtained with respect to the NDA for Qutenza with the FDA, including the PDUFA date for the NDA; plans and timing for commercialization of Qutenza; and development activities for NGX-1998 and other product candidates, including regulatory submissions and any outcomes of such submissions. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to: positive results in clinical trials may not be sufficient to obtain FDA approval; the FDA may request additional clinical trials or other information prior to granting approval for Qutenza; any regulatory approvals which are received may be limited to certain indications; NeurogesX' product candidates may have unexpected adverse side effects or inadequate therapeutic efficacy or tolerability; physician or patient reluctance to use Qutenza or NGX-1998, if approved; and other difficulties or delays in, clinical development of, and obtaining regulatory approval for NeurogesX' product candidates. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.

    NeurogesX, Inc.               The Ruth Group
    Stephen Ghiglieri             Sara Pellegrino (investors)
    Chief Financial Officer       (646) 536-7002
    (650) 358-3310                spellegrino@theruthgroup.com

                                  Jason Rando (media)
                                  (646) 536-7025
                                  '/>"/>
SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NeurogesX Appoints New Board Director and Audit Committee Chairman
2. NeurogesX Reports Second Quarter 2009 Results
3. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
4. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
5. NeurogesX Added to Russell 3000 Index
6. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
7. NeurogesX to Present at Needham Life Sciences Conference
8. NeurogesX Receives European Commission Approval for Qutenza(TM)
9. NeurogesX Reports First Quarter 2009 Results
10. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
11. NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 a2z Inc. announces ... Mobile App, AACC Pathfinder, in its 2014 Annual ... annual meeting is planned for July 29-31, 2014 in ... to be to connect with global leaders in clinical ... and other areas of breaking science in laboratory medicine. ...
(Date:7/22/2014)... Web) July 21, 2014 (PRWEB) July 23, 2014 ... Biomaterials, at Rutgers University. , The goal ... ideas across the full spectrum of scientists working ... research and development topics that represent the most ... been programmed to:,     Provide faculty ...
(Date:7/22/2014)... and Technology (NIST) and California Institute of Technology ... atomic clock that is based on a chip-scale ... clock, featured on the cover of the inaugural ... is the first demonstration of all-optical control of ... frequencies to lower microwave frequencies. (Optical frequencies are ...
(Date:7/22/2014)... , July 22, 2014   BioTE ... therapy using natural, bio-identical hormone pellets, today announced ... MD to the company.   Dr. Rouzier is joining ... physician.      Dr. Rouzier was residency ... UCLA and is a board certified emergency physician ...
Breaking Biology Technology:AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2'Comb on a chip' powers new NIST/Caltech atomic clock design 2Dr. Neal Rouzier Joins BioTE Medical 2Dr. Neal Rouzier Joins BioTE Medical 3
...  Signaling a further commitment to expand its business model in ... of the largest imaging and cardiac safety core labs ... the opening of an office in Tokyo, Japan under the ... "We are pleased to announce the creation of our new ...
... Wis., Jan. 16, 2012 PuraMed BioScience, Inc. (OTCBB:PMBS) ... Baacke, CPA, to the position of Chief Financial Officer. ... the Corporate Controller for PuraMed BioScience, Inc. gaining extensive ... came to PuraMed after holding a supervisory position at ...
... Regenesis Biomedical, Inc., a medical technology company that ... Scott Brooks has joined the company in the ... is responsible for helping scale the organization,s capabilities ... (Logo: http://photos.prnewswire.com/prnh/20120109/LA31405LOGO ) ...
Cached Biology Technology:CoreLab Partners Opens Office in Tokyo, Japan 2PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO 2Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer 2
(Date:7/23/2014)... the world by 2050, according to one of the ... (IPCC), may be advantageous to the physiology and the ... forage plants such as Stylosanthes capitata Vogel , ... such as Brazil., The conclusion is from a study ... at the Ribeiro Preto Faculty of Philosophy, Sciences and ...
(Date:7/23/2014)... MA -- What do mollusks, starfish, and corals ... habitat, they are all calcifiersorganisms that use calcium ... and shells for stability and protection. , The ... published by the Marine Biological Laboratory, addresses the ... changes worldwide. , As atmospheric carbon dioxide rises, ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):An increase in temperature by 2050 may be advantageous to the growth of forage plants 2An increase in temperature by 2050 may be advantageous to the growth of forage plants 3An increase in temperature by 2050 may be advantageous to the growth of forage plants 4Calcification in changing oceans explored in special issue of The Biological Bulletin 2MedNet Appoints Clareece West As Chief Operating Officer 2
... Nanoparticles will soon be used as tiny shuttles to ... a more targeted way than was possible in the ... the nanoparticles in medicine, concerns have arisen about their ... nanoparticles and their toxicity rely on the ability of ...
... Mass. April 28, 2011 A project to use ... $100,000 grant from The Bill & Melinda Gates Foundation today. ... of the Harvard School of Engineering and Applied Sciences (SEAS) ... aim is to develop a Microbial Fuel Cell-based charger that ...
... One of the most critical tasks that a dividing ... set of genetic information to each new daughter cell. Now, ... issue of the journal Cell , provides fascinating new ... segregation of human chromosomes during cell division. During ...
Cached Biology News: Inverting a standard experiment sometimes produces different results 2 Inverting a standard experiment sometimes produces different results 3Harvard's engineering school receives $100,000 Grand Challenges Explorations grant 2Harvard's engineering school receives $100,000 Grand Challenges Explorations grant 3New insight into chromosome segregation: Centromere-independent kinetochore assembly 2
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds....
... Human serum is obtained from normal human ... by a test for Human Immunodeficiency Virus ... Virus (Anti-HIV 1/2), Hepatitis C Virus (HCV), ... (HbsAg) and Non-reactive by a screening test ...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
Values of steady state parameters for enzyme activities are determined....
Biology Products: